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The Centers for Medicare and Medicaid are requiring long-term care facilities (LTCFs) to 
implement antibiotic stewardship programs (ASPs) to alleviate overuse of antibiotics in the 
nursing home population. Current research shows that the benefits of ASPs include improved 
patient outcomes, reduced adverse events related to Clostridium difficile (C-diff) infection, 
improvement in rates of antibiotic susceptibilities, and optimized resource utilization. This 
project addressed the problem of antibiotic overuse and misuse in the geriatric population and 
whether the implementation of an ASP reduced the overuse of antibiotics, C-diff infection, and 
resistance rates in the LTCF.  Application of the Johns Hopkins nursing model and Centers for 
Disease Control framework informed this project. An ASP was implemented by the organization. 
This project evaluated the program preASP and postASP over a 10-month period. A descriptive 
analysis was used to compare the number of new antibiotic starts, C-diff cases, and resistant 
cases before and after ASP implementation.  The total number of cases of resistance declined 
from 12 to 10 cases after the ASP was implemented, which was a 16.67% decline. The number 
of monthly new antibiotic orders for the time period evaluated declined from 120 to 110 
respectively, which was an 8.3% change. There was no change in the number of C-diff 
infections. The results demonstrated that implementing the ASP led to a decline in antibiotic 
misuse, overuse, and resistance cases. This project supports social change by expanding the 
healthcare team’s knowledge regarding the project problem and informing future interventions to 
be implemented to help reduce antibiotic overuse and misuse in the geriatric population. 
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Section 1: Nature of the Project 
Introduction 
Antibiotic overuse and over ordering is a problem nationwide. Antibiotics are to be used 
to fight infections caused by bacteria (U.S. Food and Drug Administration, 2017). Slowing down 
the use of antibiotics and assessing the need for them will help retain the efficacy of the 
antibiotics (Sprenger, 2015). Antibiotic sstewardship programs (ASPs) have been proven to 
reduce antibiotic overuse, over ordering, and the adverse effects of resistance and Clostridium 
difficile (C-diff) (Sprenger, 2015). In a study conducted in 610 general practices in the United 
Kingdom, researchers found that prescribing fewer antibiotics for colds, ear infections, and 
coughs helped to prevent resistance (Guilford et al., 2016). The Centers for Disease Control 
(CDC) stated that any action taken regarding improving antibiotic use is expected to have a 
positive impact on the residents, resistance, and the adverse effect of C-diff (U.S. Department of 
Health, 2015). Improving the quality of care provided and safety for one’s patients is the 
rationale for implementing ASPs. The implementation of an ASP at a long-term care facility 
(LTCF) impacts social change within the elderly population by affecting the residents, hopefully, 
with positive outcomes of lowered C-diff infections and resistant cases. The awareness of 
antibiotic usage will increase nursing knowledge, potentially leading to social change. This 
project supports Walden University’s mission to promote positive social change. The question I 
sought to answer with this project is: In the geriatric population, does the implementation of an 






The Centers for Medicare and Medicaid (CMS) is requiring LTCFs to implement ASPs 
(Mongan, 2015, para. 1). These stewardship programs are to alleviate overuse of antibiotics in 
the nursing home population (citation). Current research shows that the benefits include 
improved patient outcomes, reduced adverse events related to C-diff infection, and improvement 
in rates of antibiotic susceptibilities to targeted antibiotics with optimized resource utilization 
across the continuum of care (Barlem et al., 2016). Antibiotic overuse is of great concern in 
LTCFs and, in response to this concern, the CDC and the CMS have mandated that LTCFs 
implement ASPs to help eliminate the overuse of antibiotics in the elderly population (citation). 
Antibiotic use in LTCFs is an issue that needs to be addressed nationwide to slow the emergence 
of antibiotic-resistant bacteria (Dall, 2016).  
According to Johns Hopkins (Ahern Gould, 2017), antibiotic resistance is an issue that 
must be addressed by healthcare providers and patients. The increasing cost of antibiotics, the 
rate of new antibiotics being introduced, and the resistance issues being seen makes it difficult 
for the health care provider to choose the optimal antibiotic today (citation). It has been through 
history that if health care professionals are not careful, antibiotics will lose their efficacy (Ahern 
Gould, 2017). On a local level, the city of Houston, Texas has established its own Antimicrobial 
Stewardship Committee, comprised of clinical experts, to address the antibiotic resistance 
problem in the Houston area with the goal to work with other community members in the area to 
preserve antibiotics (Offiong, 2017). In addition, the CDC has provided the city of Houston with 
a grant to host an annual symposium to combat this practice problem of antibiotic resistance 





According to the CDC (2017) antibiotic stewardship requires national attention. The 
CDC has identified antibiotic misuse and overuse as a gap in practice and has developed multiple 
goals to address this issue. The goals include establishing national guidelines on antibiotic use 
and cutting inappropriate prescribing (citation). In addition, the CDC includes the initiative that 
CMS (2015) adopted for implementation of ASPs, which is mandated in LTCFs (U.S. 
Department of Health, 2017). The practice question is: In the geriatric population does the 
implementation of an ASP reduce the overuse of antibiotics and affect C-diff rates in the LTCF 
compared with no ASP? Doctor of Nursing Practice (DNP) scholarly projects are those that are 
focused on changing outcomes using evidence-based practice (Terry, 2015). In this doctoral 
project, the problem was antibiotic overuse, and the intervention to address the problem was a 
newly implemented ASP at the practicum site. The scholarly project focused on whether 
antibiotic overuse declined with the implementation of the ASP and whether the development of 
the adverse outcome of C-diff and resistance was affected by the implementation of an ASP. 
This scholarly project evaluated a current healthcare practice or program, the ASP. Antibiotic 
overuse is of great concern in LTCFs and in response to this concern the CDC and the CMS have 
mandated that LTCFs implement ASPs to help eliminate the overuse of antibiotics in the elderly 
population (citation). Antibiotic use in LTCFs is an issue that needs to be addressed nationwide 
to slow emergence of antibiotic-resistant bacteria (Dall, 2016).  
Nature of the Doctoral Project 
In this doctoral project, I evaluated the problem of antibiotic overuse and the effects of a 




declines with the implementation of the ASP and whether the development of the adverse 
outcome of C-diff and resistance is affected by the implementation of an ASP within this LTCF. 
The sources of evidence that were collected for this project included the number of new 
antibiotic starts and the number of C-diff and resistant infections comparing pre-ASP to post-
ASP implementation. The nurses documented monthly on antibiotic tracking logs all new 
antibiotic starts, cases of resistance, and positive cultures for C-diff. The facility staff collected 
and de-identified the data for the project and provided it to me. The approach used to organize 
and analyze the evidence was the CDC and Institute for Healthcare Improvement (IHI) for 
effective implementation of an ASP change driver framework (U.S. Department of Health, 
2017). It was anticipated that the prevalence of new antibiotics ordered, the number of resistant 
cases, and C-diff infections would decrease post-ASP implementation.   
Significance 
The stakeholders at the LTCF for the ASP included the director of regulatory compliance, 
quality assurance nurse, medical director, laboratory consultant, pharmacist consultant, director 
of nurses (DON), assistant director of nurses (ADON), nursing staff, physicians, and family 
members. Table 1 describes the roles, responsibilities, and tasks for each stakeholder for this 
project. Each stakeholder had an important part in the successful implementation and 
maintenance of the ASP. The stakeholders had a vested interest in reducing antibiotic use and the 








Stakeholder roles, responsibilities, and tasks 
Director of Nurses 
(DON) 
Co-champion and infection control lead. Co-develop agendas. 
Lead / Supervise trainings. 
Ensure Monitoring of the new interventions. 
Help develop staff training. 
Review whether materials are used. 




Compliance   
Champion  
Medical Director Champion 
Quality Assurance 
(QA) Nurse  
Monitoring Staff: Collect/Analyze/Aggregate Data to evaluate 
program effectiveness and sustainability  
Assistant Director 
of Nurses (ADON)  
Stewardship Staff: Assist with program education to nurses and 
implementation of program 
Minimum Data Set 
(MDS) Nurse  
Stewardship Staff: Assist with program education to nurses and 









Assist with antibiogram annually and provide culture reports and 
summaries for the LTCF 
 
The end users, which are those individuals who will be implementing/using the ASP, 
included the lab personnel, pharmacy personnel, physicians, nurse practitioners, nurses, 
administrator, and the QA registered nurse (RN). Engaging the stakeholders and end users was 
an important step in the success of sustaining the ASP. Ensuring that one considers the opinions, 
key information, and input of the stakeholders helps to establish the plan with everyone’s input 




project. Slowing down the use of antibiotics and assessing the need for them will help retain the 
efficacy of the antibiotics (Sprenger, 2015).  
Block (2016) shared that ASPs have been proven to reduce antibiotic overuse, over 
ordering, and the adverse effects of resistance and C-diff. If antibiotic prescriptions are 
appropriate and careful consideration is employed when ordering antibiotics, resistance will 
decline, which will improve patient safety from adverse effects and improve the quality of care 
provided (Lee, Cho, & Lee, 2013). A desired result of implementing an ASP at this LTCF was to 
improve the quality of patient care in that there will be a sustained reduction in inappropriate 
antibiotic therapy being prescribed and a reduction in adverse effects from antibiotic overuse and 
over ordering. Antimicrobial stewardship is an important step in reducing resistance (Zukowski, 
2016). This doctoral project could potentially be modified to be used in clinics, doctor offices, 
and home health agencies. Increasing nurses’ awareness of antibiotic usage, this practice 
problem, and implementing antibiotic stewardship programs will increase nursing knowledge, 
potentially effecting social change in this practice area by reducing overuse and misuse of 
antibiotics.  
Dall (2016) shared that between 40% and 70% of antibiotics prescribed are inappropriate 
to residents in LTCFs. Over 23,000 people die each year due to the adverse effect of antibiotic 
resistance and more than 2 million people become infected with resistant bacteria (citation). If 
nothing is done this can become over 10 million lives by 2050 (Nevada Public Health, 2017).  
Summary 
Antibiotic overuse and over ordering is a practice problem that must be addressed at this 




Organization (WHO) is requesting that all countries develop an antimicrobial action plan (WHO, 
2016). The city of Houston has developed an antimicrobial stewardship committee and is 
working to reduce antibiotic overuse and over ordering (Offiong, 2017). CMS has mandated that 
LTCFs implement an ASP to assist in combating this problem (U.S. Department of Health, 
2015). This doctoral project evaluated the effectiveness of implementing an ASP relating to 
antibiotic overuse and C-diff infection rates. The CDC/IHI framework was used to measure the 
effectiveness of the ASP program preimplementation versus postimplementation over a 10-
month period. The facility staff documented, tracked, and collected data on logs capturing all 
new antibiotic starts, resistant cases, and C-diff infections before and after implementation of the 
ASP. It was anticipated that the implementation of the ASP would result in a decrease in 
antibiotic starts, cases of resistance, and in C-diff rates. The model, relevance to nursing practice, 
local background and context, role of the DNP student, role of the project team and will be 













Section 2: Background and Context 
Introduction 
Antibiotic overuse and misuse is a problem in LTCFs (Lockhart, 2017). Lockhart (2017) 
posited that overusing antibiotics leads to resistance and when one needs antibiotics they may not 
be effective. The purpose of this project was to evaluate the effectiveness of an ASP in the LTCF 
setting related to overuse, resistance, and clostridium difficile infections. The question I sought 
to answer in this project was: In the geriatric population, does the implementation of an ASP 
reduce the overuse of antibiotics, C-diff, and resistance rates in the LTCF compared with no 
ASP? ASPs are necessary to reduce the misuse and over ordering of antibiotics and the adverse 
effects of resistance and C-diff (Tiberg, Torney, & Vanderhorst, 2017). ASPs are required in the 
LTCF to provide a higher level of safety for all residents. Residents in high-use nursing homes 
are at risk even if they did not take antibiotics themselves (Daneman et al., 2015). When 
planning translational activities and goals for projects, it is important to include the mission and 
operational practices of the organization (White, Dudley-Brown, & Terharr, 2016).  
I chose the Johns Hopkins model for the project, along with the CDC and IHI change 
driver framework for ASPs. In this section, I will discuss the concepts, models, and theories, 
relevance to nursing practice, local relevance of the problem, role of the DNP student in relation 
to the doctoral project, and role of the project team.  
Concepts, Models, and Theories 
The Johns Hopkins model was chosen as the project model for this ASP quality 
improvement project due to its viability and because it was the best fit. The Johns Hopkins 




Medicine, 2017). The practice question is as follows: “In the geriatric population does the 
implementation of an ASP reduce the overuse of antibiotics and affect C-diff rates in the LTCF 
compared with no antibiotic stewardship program?”. According to the LTCF practicum site 
mission, vision, goals, and operational practices, their professional staff is "committed to serving 
the needs of the independent retirement, assisted living, and healthcare residents with respect, 
kindness, and hospitality" (citation, p.1). The mission statement further presented this LTCF as a 
place for everyone, regardless of how much help they need (citation). The fact that this LTCF 
community was described as being filled with loving people who are ready to welcome their 
patients (C. Klappenbach, personal communication, November 8, 2017) was part of the planning 
for this project. Application of the Johns Hopkins nursing model to the ASP project in the LTCF 
included development of the practice question, evidence searches, critique of the evidence, 
summary of the evidence, and evaluating the strength of the evidence (see White, 2016). The 
second phase (evidence) included searches regarding ASP development, implementation, and 
evaluation in the past 5 years that are authoritative (citation). The third phase included evaluation 
of the ASP at the LTCF. The final phase, per White (2016), included implementing, evaluating, 
developing tools, and communicating findings. The practicum site has implemented the ASP, 
collected the data, and communicated the findings through the ongoing quarterly quality 
assurance meetings. As a DNP student, I analyzed and evaluated the data related to the outcomes 
for antibiotic use, C-diff infection, and resistance rates before and after ASP implementation. 
The framework chosen for this project was the antibiotic sstewardship measured framework 
established by the CDC in collaboration with the IHI for effective implementation of an ASP in 




This model has been explained by Schaffer et al. (2013) as a nursing practice model that 
identifies the EBP question using a team approach, includes research and critique, and develops 
recommendations based upon the strength of the evidence. The model also helps determine the 
feasibility while creating an action plan, implementing change, evaluating, and communicating 
findings (Schaffer et al., 2013). Newhouse (2007) defined the Johns Hopkins evidence-based 
practice model as a model of evidence, whereby such evidence assists in making decisions about 
nursing practice, education, and research. The quality of the research, its relevance to the clinical 
setting, and whether the benefit of it is greater than any negative effects were considerations 
when choosing a model to affect nursing practice (Newhouse, 2007).  
The framework (CDC/IHI Antibiotic Stewardship Drivers and Change Package) included 
the conceptual model with the key drivers for implementing and providing a change package for 
decreasing antibiotic misuse and assisting facilities to have positive resident outcomes (U.S. 
Department of Health 2017a). The intent of the change package was to establish a 
multidisciplinary team that works collaboratively to implement the interventions over time to 
positively impact and reduce inappropriate antibiotic use (U.S. Department of Health, 2017). The 
CDC/IHI antibiotic stewardship framework provided several options for selected measures to 










Antibiotic Stewardship Measurement framework 
Outcomes Measure  
 
Healthcare-associated C. difficile  
infections 
 
Rate of healthcare-associated C. difficile per 
10,000 pt. days  
 
When C. diff is a “rare event”: days (or 
admissions) between C. diff associated disease  
 
 
Pharmacy cost for antibiotics 
 
Total pharmacy cost for antibiotics per month  
 
When census is variable: Pharmacy cost for 
antibiotics per discharge per month  
 
 
Antibiotic-related adverse drug  
events (ADEs)  
 
 
Currently not feasible with this method to 
evaluate this outcome in the time frame for 
evaluation 
 
Antibiotic resistant healthcare  
associated pathogens  
 
 
Percent of antibiotic resistant healthcare-
associated pathogens i.e. prevalence. Note: 
targeting pathogens based on local 
circumstances, i.e., MRSA, VRE, etc.  
 
(CDC, October 26, 2017).  
The measures selected for this project included prevalence rate of C-diff and resistance per 300 
patient days (10 months), or days between C-diff associated disease if found rare at the facility, 
and the number of new antibiotic starts comparing pre-ASP implementation with post-ASP 
implementation over a 10-month period from July 11, 2017 (ASP implementation date) to May 
15, 2018. Rare is defined for the scope and timeframe proposed for this project as less than two 
positive resident resistant lab results per 300 resident days. I chose an evaluation period of 300 




implemented in July 2017. The pharmacy cost measure was not chosen by me due to a lack of 
available data and a change in the pharmacy company providing services to the LTCF in the 
fourth quarter of 2017 at the practicum site.  
Relevance to nursing practice 
CMS requires LTCFs to implement ASPs to alleviate overuse of antibiotics in this setting 
(Mongan, 2015, para. 1). According to Dall (2016), 40-70% of antibiotics prescribed are 
inappropriate to residents in LTCFs. Research has shown that the benefits of implementing an 
ASP include improved patient outcomes, reduced adverse events related to C-diff infection, and 
improved rates of antibiotic susceptibilities to targeted antibiotics with optimized resource 
utilization across the continuum of care (Barlem et al., 2016). Antibiotic overuse in LTCFs is a 
problem and in response, the government passed legislation mandating that LTCFs implement 
ASPs in 2017 to help eliminate the overuse of antibiotics in the elderly population. Lockhart 
(2017) noted that antibiotic resistance can lead to death. Add summary to fully conclude the 
paragraph. 
The cost of antibiotics is increasing; the rate of new antibiotics being introduced and the 
resistance issues being seen makes it difficult for the health care provider to choose the optimal 
antibiotic today (Hopkins, 2017). Hopkins (2017) reported that is antibiotics are not prescribed 
and used carefully, the drugs can lose their efficacy. The CDC newsroom (2013) reported that 
over 20 billion dollars are spent annually on providing care to those with antibiotic resistance 
and 35 billion dollars per year are lost related to loss of productivity, when one cannot work due 
to illness. There are five core elements recommended to combat the antibiotic resistance and 




tracking resistance patterns, improving use of antibiotics (antibiotic stewardship), and developing 
new antibiotics and diagnostic tests (CDC Newsroom, 2013). Michaelidis et al. (2016) described 
hidden societal costs related to antibiotic resistance (SCAR) related to ambulatory antibiotic 
prescriptions in the United States. The hidden SCAR per antibiotic prescribed in the United 
States averaged to be $13.00 which, when calculating across four different methods, equated to 
an increase of 65% per ambulatory prescription ordered (Michaelidis et al., 2016). Knowing the 
cost of antibiotic resistance is difficult, but when comparing loss of work due to antibiotic 
resistance to other comparable health issues, the cost is conservatively from $35,000 - $55,000 
and may be more (Smith & Coast, 2013). Additional research is needed on the cost related to 
antimicrobial resistance (Smith & Coast, 2013).    
 The use and misuse of antibiotics are major contributors to the development of antibiotic-
resistant bacteria. A significant proportion of antibiotics used in LTCFs is inappropriate by drug 
selection or altogether unnecessary and places residents at risk for developing antibiotic-resistant 
infections (Hyuan, 2016). Antibiotic misuse (overordering, overusing, inappropriate use) leads to 
resistance and C-diff (Mayo Clinic, 2012). Trivedi and Schooneveld (2012) identified that 3.2 
million people currently reside in nursing homes in the United States and it is expected that this 
number will double by 2050. One long-term care study has shown that antibiotics are over 
ordered and 35% of antibiotics ordered for wound/skin problems, 42% for lower respiratory 
infections, and 72% of urinary tract infections were not clinically justifiable (Trivedi, et al, 
2012). According to the CDC (2017), antibiotic stewardship requires national attention. The 
CDC has identified a gap in practice and has developed multiple goals to address this issue. The 




hospitals, physician offices, and other healthcare environments (citation). In addition, the CDC 
included the initiative which CMS (2015) has adopted for implementation of ASPs which is 
mandated in LTCFs (US Department of Health, 2017). This project will advance nursing practice 
by helping to reduce antibiotic overuse and costs associated with care for those with antibiotic 
resistance. This project will hopefully help reduce resistance in this LTCF setting and C-diff 
occurrences. Stone (2013) posited the consequence of antibiotic misuse in nursing homes as 
extremely high and reducing the misuse leads to less resistance and adverse effects. 
Implementing an ASP is one way to reduce misuse (Stone, 2013). The CDC (2017) shared the 
annual savings related to ASP implementation at hospitals or other healthcare facilities was 
$200,000-$400,000. Add summary and synthesis to fully conclude the section. 
Local Background and Context 
 Texas is identified as prescribing antibiotics at the rate of 927/1000 population, which is 
higher than many other states in prescribing antibiotics outside of the hospital setting (Hicks, 
2017). When examining antibiotic usage in the LTCF setting, it has been identified by the 
Houston Antimicrobial Symposium (Rios, 2017) that citywide antimicrobial stewardship 
programs may help to overcome some of the barriers. In LTCFs, over the course of a year, up to 
70% of nursing home residents get an antibiotic (CDC, 2017). In nursing homes, high rates of 
antibiotics are prescribed to prevent urinary tract infections (UTI) and respiratory tract infections 
(RTI). Prescribing antibiotics before there is an infection often contributes to misuse (CDC, 
2017).  
 The practice setting for this scholarly project was a 62-bed long-term care skilled nursing 




there is an independent living (IL) facility and an assisted living facility (ALF). The federal 
government is requiring all LTCFs to implement ASP's (Stone, 2013). Under the Centers for 
Medicare and Medicaid, rule F881, ASP's must be in place by November 2017 (Dall, 2016). The 
facility had no ASP prior to July 1, 2017 and recently developed and implemented its antibiotic 
stewardship program in July 2017. The facility had an average census of 36 residents from July 
1, 2016 to July 1, 2017 with 8.75 new antibiotic starts per month. Twenty-two percent of the 
population had antibiotics started each month and not all residents had a culture to substantiate 
the antibiotic. my role within this project was to lead and analyze the data collected by the 
practicum site and evaluate the outcomes based on the data provided. I had worked with this site 
during the clinical practicum for the doctoral program developing and implementing an 
evidence-based project which was the development and implementation of an ASP. The 
proposed time for the stewardship program was over a 10-month period from July 2017 through 
May of 2018. The data collection was conducted daily by the facility nurses each time a new 
antibiotic was ordered. The data collected by the facility included capturing new starts, resistant 
organisms, and those who were diagnosed with C-diff. This ongoing data collection was used for 
the doctoral project. The facility staff was educated on data collection and the ASP program 
during the evidence-based project development phase and will be re-educated as needed. In 
addition to data collection on monthly flow logs, chart audits were conducted on each client with 
a new antibiotic start to ensure all components of the ASP were being followed. The Quality 
Assurance department captured the data in a summary format and presented it to management on 
a quarterly basis. The number of new antibiotic starts, cases of resistance, and number of C-diff 




is less than two resident occurrences in the proposed time, this was defined as rare and if this 
occurred then the number of days between diagnosis of C-diff occurrences were counted.    
Role of the DNP student 
 The role of the DNP student was to lead the doctoral scholarly project in collaboration 
with the site, review the data collected, evaluate the data, communicate with the ASP team, 
synthesize the outcomes, and develop an outcome report. The doctoral student functioned as the 
interim leader for the project and provided guidance and a quality review of the data collected 
and aggregated to ensure the program was being implemented and sustained as designed and in 
accordance with the federal regulations. The doctoral student evaluated the data outcomes to 
determine if the implementation of the ASP in this LTCF reduced the number of new starts, 
resistance, and C-diff cases. The motivation in choosing this project was the desire to positively 
affect outcomes in the geriatric population related to antibiotic overuse. The elderly population is 
one that is vulnerable to antibiotic overuse and needs assistance in this area due to their health 
and frailty. This student had a bias which is that not all staff may want to do their best in 
focusing on implementing and sustaining the ASP. To overcome this bias, the doctoral student   
recognized the bias and to overcome the bias, maintained an open mind when working with the 
staff and maintained objectivity throughout the project by being open-minded. Friedman (2017) 
shared being open and aware of one's own bias will help to deepen relationships and remove 
barriers. The doctoral student employed the American Association of Colleges of Nursing 
(AACN, 2007) eight fundamental essentials demonstrating the doctoral student competencies in 






AACN Essential Competencies of a DNP student  
DNP Essential Tasks in the course project/DNP Essential 
1.Scientific Underpinnings for Practice DNP student to assess patterns of human 
behavior related to their environment (elder 
persons, their environment, antibiotic use and 
resistance) and develop and apply nursing 
actions or processes to affect antibiotic misuse 
and provide positive change in health status  
2.Organizational and Systems Leadership for 
Quality Improvement and Systems Thinking  
Target population- geriatric;  
DNP student to propose strategies for 
improvement in practice related to antibiotic 
use   
3.Clinical Scholarship and Analytical Methods 
for Evidence-Based Practice 
Literature search, best practices, design, direct, 
evaluate a quality improvement related to 
antibiotic stewardship program in a LTCF 
4.Information Systems/Technology and Patient 
Care Technology for the improvement and 
Transformation of Health Care  
DNP student to use web-based learning for 
staff needs assessment and design evaluation 
for this quality improvement activity 
5. Health Care Policy for Advocacy I Health 
Care 
DNP student assumes leadership role for this 
quality improvement activity advocating for 
improvement in antibiotic stewardship in this 
LTCF 
6. Inter-professional Collaboration for 
Improving Patient and Population Health 
Outcomes  
DNP student will lead and employ effective 
communication among the team at this LTCF 
for this quality improvement project   
7. Clinical Prevention and Population Health 
for Improving the Nation’s Health  
DNP student will collect and analyze data for 
the geriatric population relating to antibiotic 
misuse and apply strategies for improvement 
8. Advance Nursing Practice   A comprehensive and systematic assessment of 
the geriatric population in a LTCF for 
antibiotic stewardship programming will be 
conducted and evaluated by the DNP student  
 (ACCN, 2006) 
Role of the Project Team 
  The role of the ASP project team assembled for this project was multi-faceted. The ASP 




submitted by the QA nurse; work with the team in identifying areas needing improvement, 
remediation, re-education of the staff, and established plans to implement the next phase of the 
ASP as mandated by federal law which is the Infection Preventionist infection control position 
by November 28, 2019 (Tritz, 2016). The Infection Preventionist is an individual who is highly 
qualified in infection control and either has a bachelor's degree in epidemiology, microbiology, 
medical technology, public health, or other healthcare science or is a healthcare professional with 
specialized training in infection prevention and control beyond their initial professional degree as 
outlined in federal regulation for LTCF 483.80 (CMS, 2017). Ongoing specialty training in 
infection prevention and control through accredited continuing education and a nationally 
certification in Infection Prevention and Control by NADONA (IP-BC Credential) or completion 
of certification (CIC) Certification in Infection Control, or Certification Board of Infection 
Control (CBIC) within 12 months of employment may also be required (CMS, 2017). 
The process by which the team was presented with background information, evidence, 
and other forms of information was two-fold, by email and face-to-face meetings. The team 
members were expected to have shared their expertise with the internal/external organizational 
operating systems within the facility, knowledge of the residents and rules and regulations, and 
provided feedback within a timely manner to the members of the team. The team members did 
not provide evidence for the project. Timely team communication was defined as within two 
business days. Sandau and Dedrick (2012) shared evidence-based projects are a life-long process 
and one should continue to research and find the most recent evidence to continually evaluate the 
project and move forward. As the practicum site began this long journey of sustaining the ASP 




based on the most current research. In December 2017 the facility QA Nurse retired after 25 
years of service and the DON assumed the QA Nurse position. The DON had been on the ASP 
team and has the knowledge for the program but changed roles within the team. This has 
benefited the facility in that their QA department gained a previous ASP team member with 
familiarity and leadership within the program previously. The LTCF has an antibiotic 
stewardship team who will continue working, evaluating, and identifying the outcomes of the 
program and reviewing its effectiveness and sustainability over time, beyond this project. The 
ASP team members have defined roles in the program which are outlined in Table 4. 
Table 4 
ASP team member roles 
DON Co-champion and infection control lead.  
Lead / Supervise trainings. 
Ensure monitoring of the interventions. 
Monitor staff training. 
Review whether materials are used 
Develop findings with Performance Improvement Plan 
(PIP) related to monitoring the new intervention. 
Administrator  Champion  
Medical Director  Champion 
Doctoral Student  Evaluate program implementation, effectiveness, data 
collection, trends, barriers, challenges, sustainability, 
outcomes  
Quality Assurance Nurse  Monitoring staff: Collect/analyze/aggregate data monthly 
to evaluate program effectiveness and sustainability 
Assistant Director of 
Nurses  
Stewardship staff: Assist with ongoing program education 





Minimum Data Set Nurse 
(MDS) 
Stewardship staff: Assist with ongoing program education 




Consulting Pharmacist  Co-champion, Antibiotic stewardship trained and 
infectious  disease knowledgeable, reviews antibiotics 
monthly for the facility residents who are ordered 
antibiotics  
Lab  Co-champion 
Antibiotic stewardship bio gram and meet with 
stakeholders on cost and reports monthly 
 
Summary 
This section focused on the CDC/IHI and Johns Hopkins model for ASPs, the relevance 
of antibiotic misuse and overuse in the geriatric population, the relevance to nursing practice, and 
discussed antibiotic stewardship issues and efforts in Houston, Texas. In addition, the role of the 
DNP student and ASP project team were discussed in detail. Next, the problem of antibiotic 
overuse in Houston, Texas, the project plan for addressing this issue, an introduction to the 
sources of evidence, operational data, and an analysis and synthesis of the data to be collected 




Section 3: Collection and Analysis of Evidence 
Introduction 
 The use and misuse of antibiotics are major contributors to the development of antibiotic-
resistant bacteria. A significant proportion of antibiotics used in LTCFs is inappropriate by drug 
selection (or choice), or altogether unnecessary, and places residents at risk for developing 
antibiotic-resistant infections (Hyuan, 2016). Houston, Texas has developed an Antibiotic 
Stewardship Community Symposium to address the issues of antibiotic misuse and overuse 
(Rios, 2017). In this section, I will further explore and explain the problem, gap-in-practice, and 
project purpose. The sources of evidence relied upon to address the practice-focused question 
and collection of data with analysis are presented and approved. I will also summarize the 
databases and search engines used for the project and discuss the organization’s operational data 
used for the project. This section will also include analysis and synthesis of the participants, data 
collected, and evaluation methods.  
Practice-Focused Question   
 Over prescribing antibiotics in the Houston area is a problem. Rios (2017) noted that a 
lack of appreciation for antibiotic resistance, knowledge, and a lack of resources are contributing 
to the problem. Implementing city-wide ASPs can help to reduce barriers (Rios, 2017). The 
purpose of this DNP project was to evaluate the effectiveness of reducing resistance, overuse, 
and C-diff and to determine whether, in the geriatric population, the implementation of an ASP 
reduces the overuse of antibiotics, C-diff, and resistance rates in the LTCF compared with no 
ASP. The ASP was implemented in July 2017 and included policies, procedures, forms, staff and 




monthly analysis of new antibiotics ordered, and development of an ASP team. The QA nurse 
gathered the data collected and prepared the quarterly reports regarding the ASP program. The 
CDC (2017) recommends various ways in which a nursing home can measure the ASP and its 
outcomes. The outcome measures selected for this project included prevalence rate of resistance, 
C-diff per 300 patient days (10 months), or days between C-diff associated disease if found rare 
at the facility, and the number of new antibiotic starts before and after ASP implementation over 
a 10-month period. Rare was defined for the scope and timeframe proposed for this project as 
less than two positive resident resistant lab results per 300 resident days. The data collection 
methods included the LTCF nursing staff documenting entries daily as applicable on monthly 
logs on each unit in the LTCF of all residents with new antibiotic starts, cultures verifying 
positive C-diff or resistance, chart audits on those residents who have antibiotics ordered, 
laboratory antibiograms, and an analysis of the number of C-diff infections pre-ASP 
implementation versus postimplementation.  
Sources of Evidence  
The sources of evidence relied upon for the practice-focused question Clostridium 
difficile included searches using a variety of sources within the past 5 years (2012-2018). The 
search strategies implemented included data searches to acquire the necessary scholarly literature 
supportive of the project. The sources of evidence align with the purpose of the project, which 
was to evaluate the effectiveness of an ASP in the LTCF setting relating to overuse, resistance, 
and C-diff infections. The following is a list of sources of evidence used in this scholarly project: 
• Walden Library 




• Governmental entities  
• Centers for Disease Control 
• Centers for Medicare and Medicaid Services 
• Searches using key words antibiotic stewardship, long-term care, CMS mega-rule, 
antibiotic misuse, antibiotic cost, and antibiotic resistance 
• CINAHL 
• Medline 
• Cochrane Database of Systematic Reviews 
• Free Medical Journals 
• Walden Research Center  
• Agency for Healthcare Research and Quality 
• Institute for Healthcare Improvement 
• Google searches for antibiotic stewardship programs in long-term care facilities 
• State Operations Manual 
• World Health Organization 
• Houston Antibiotic Stewardship Symposium  
The data were collected by the LTCF QA nurse using the following tools: (a) a unit 
tracking log for nurses to document all new antibiotic starts, (b) a QA chart audit tool to evaluate 
whether antibiotics ordered have a diagnosis, lab result on file, or diagnostic test with result 
(prior to antibiotic being ordered), and duration for the antibiotic, as required by the ASP, (c) a 
monthly summary tool to capture and track new antibiotic start data on a spreadsheet, and (d) a 




 The CDC (2017) indicated that tracking infections, conducting surveillance, auditing 
records, reviewing lab results, evaluating the antibiotic orders. In addition, documentation, use, 
and duration are all important elements in evaluating the ASP (U.S. Department of Health, 
2015). Tracking the number of antibiotic starts, cases of C-diff, and resistance are approved 
methods for evaluating the impacts of the ASP (U.S. Department of Health, 2015) and are being 
employed for this quality improvement project.  
Collecting data relating to the number of new antibiotic starts, cases of C-diff, and 
resistance before and after ASP implementation by the facility staff allowed for an evaluation of 
the effectiveness of the ASP program on resistance, overuse, and C-diff within this LTCF 
(Ibrahim & Polk, 2014). The staff had been collecting the number of new antibiotic starts, cases 
of C-diff, and resistance prior to the implementation of the ASP in July 2017 and continue to 
collect this data daily (C. Klapennebach, personal communication, November 8, 2017). Ibrahim 
and Polk (2014) explained that "measurement of antimicrobial use before and after an 
intervention and the associated outcomes are key activities of antimicrobial stewardship 
programs" (p. 1). Testing data before implementation of an ASP and after implementation is a 
recommended method called the nonexperimental design pre-and post-ASP design (Ibrahim, et 
al., 2014). This collection method provided appropriate outcome data to evaluate the outcome of 
the project, which was to evaluate the effectiveness of an ASP in a LTCF on C-diff, resistance, 
and overuse/misuse of antibiotics.  
 The data collection methods included the LTCF nursing staff documenting entries daily 
as applicable on monthly logs on each unit in the LTCF of all residents with new antibiotic starts, 




had antibiotics ordered, laboratory antibiograms, and an analysis of the number of C-diff 
infections pre-ASP implementation versus postimplementation. The data was collected by the 
LTCF QA nurse for evaluation and analysis: Unit tracking log for nurses to document all new 
antibiotic starts; a QA chart audit tool to evaluate if antibiotics ordered had a diagnosis; lab result 
on file or diagnostic test with result (prior to antibiotic being ordered); and duration for the 
antibiotic, as required by the ASP; a monthly summary tool to capture and track new antibiotic 
start data on a spreadsheet; and a QA quarterly report inclusive of new antibiotic starts to display 
outcome data quarterly.  
 The data was verified by the QA nurse while conducting reviews of the medical records, 
culture reports, Best lab monthly reports, and Relias documentation by the nursing staff. In 
addition, the unit manager verified the accuracy of the monthly log before it went to the QA 
nurse by reviewing the lab reports and orders and comparing the information to the log. The unit 
manager and QA nurse were responsible for ensuring that information was not missing and was 
correct by the reviews they were conducting.  
Analysis and Synthesis 
 The systems used for recording, tracking, and organizing the evidence in this DNP ASP 
evaluation project included the following: Best lab monthly reports on the number of antibiotics 
ordered, an annual bio gram provided by Best lab, monthly infection control antibiotic unit logs, 
laboratory culture reports, resident medical records, and the Relias software system (Relias, 
2018) used by the nurses and QA department. The lab was using its own software system that 
tracks each patient who has an antibiotic ordered, culture results, or cost related to antibiotic 




personal communication, December 5, 2017). In addition, the facility, effective March 15, 2018, 
was using the Relias software to input antibiotic orders, track lab and culture orders, and print 
reports from this system monthly (K. Weathers, personal communication, February 27, 2018). 
The Relias system provides electronic data, unlike the manual logs the facility was keeping. The 
number of new antibiotic starts, number of C-diff cases, and number of resistant cases were 
counted for each month before ASP implementation and compared to the number of cases after 
ASP implementation to evaluate or determine the effect the ASP had on antibiotic overuse, cases 
of C-diff, and cases of resistance at this LTCF. I coded the data, some preset codes and some that 
evolved or emerged during data analysis. Outliers such as unnecessary therapy, prolonged 
durations, and unusual resistance patterns were evaluated by the QA nurse (Ibrahim, et al., 
2014). Patient information was de-identified and summarized in the QA reports by the ADON 
which I used to evaluate and analyze the data to compare the number of new antibiotic starts, C-
diff cases, and resistant cases before and after ASP implementation. I shared the data outcomes 
with the stakeholders via a formal presentation at the end of the project.   
Summary 
 The practice problem of antibiotic overuse and misuse is an issue nationwide (Hyuan, 
2016). In the Houston area, an antibiotic stewardship symposium group has been assembled to 
help combat this problem on a local level, and nursing homes have been mandated to implement 
ASPs. In this section, I identified many sources of evidence to support this practice problem and 
explained that data has been collected ongoing at the LTCF pre-ASP implementation (July 2017) 
and is ongoing. The number of new antibiotic starts, cases of C-diff, and resistance were 




section will expand upon the findings, implications, and recommendations relating to the effect 
the ASP had on this facility. The project team's role, strengths and limitations of the project, and 
dissemination of this work will be presented and discussed. Finally, an analysis of self will be 
shared relating the dnp student to the different roles assumed throughout the project and in 




Section 4: Finding and Recommendations 
Introduction 
 Antibiotic over use and inappropriate use continues to be problematic in the LTCF 
environment. There are four core elements to reducing resistance which include preventing 
infections, tracking resistance patterns, improving antibiotic use (stewardship), and developing 
new antibiotics and tests (U.S. Department Disease Control, 2013). The practice focused 
question is: In the geriatric population does the implementation of an ASP reduce the overuse of 
antibiotics and affect resistance and C-diff rates in the LTCF compared with no ASP? The 
purpose of the doctoral project was to evaluate the affect an ASP had on antibiotic use, overuse, 
cases of resistance, and C-diff.  
 The sources of evidence for this project covered the period from September 2016 through 
May 15, 2018 (10 months prior to ASP implementation to 10 months post-ASP implementation). 
Sources of evidence included the monthly antibiotic unit logs, physician orders for antibiotics, 
results of cultures obtained, type of infection documented on the logs and reports, monthly 
facility lab reports from Best care lab, facility census, and the quality assurance reports 
summarizing the number of new antibiotic starts monthly. The staff at the LTCF documented the 
information collected, provided the de-identified monthly antibiotic logs and lab reports for 
analysis, and assisted when questions arose, or verification of data was required. The monthly 
lab reports were compared against the unit monthly antibiotic logs to ensure that the correct 
number of resistances were recorded, the correct number of new antibiotic starts were recorded 
based on the number of positive culture results, and clarification was obtained for any 




denoted on the monthly log and were not counted. Those patients who had re-treatments for 
existing infections were counted one time. The number and types of infections were reviewed to 
ensure duplication did not occur if a resident had an ongoing infection from one month to the 
next. If a resident was diagnosed and treated with a new infection from a different source, this 
was counted. For example, if a resident had an upper respiratory tract infection in January and 
then developed a urinary tract infection in February and was treated with different antibiotics, 
these were counted as two different new start orders. The resident information was de-identified 
on the logs so to eliminate possible duplication of entries the resident room numbers were 
tracked on the monthly logs as a part of the analysis process.   
Findings and Implications  
 Upon reviewing, analyzing, and evaluating the data collected it was identified that the 
census for the facility remained fairly stable and the average daily census was 39 residents prior 
to ASP implementation and 37 after the ASP was implemented. When reviewing the effect the 
ASP had within the facility during this time period it was identified that antibiotic ordering 
declined. The facility ensured that it had culture reports consistently with results when ordering 
antibiotics. The facility reported that they did continue to use the orientation training modules for 
newly hired nurses for the stewardship program 100% of the time. The total number of cases of 
resistance over the time period evaluated declined from 12 cases prior to the ASP being 
implemented to 10 cases after the ASP was implemented. This equated to a 16.67% decline. The 
number of monthly new antibiotic orders for the time period evaluated declined from 120 to 110 
respectively which was an 8.3% change. For this population, these numbers are statistically 




were zero cases of C-diff prior to the ASP implementation and zero cases afterwards. Table 5 
outlines the findings.  
Table 5 
ASP Outcome Indicators   





Average monthly census 39 37 
 
# New antibiotic starts orders  120 110 
 
Average monthly new antibiotic orders  11.43 10.48 
 
#MRSA 5 3 
 
#VRE 4 1 
 
#ESBL* 3 6 
 
#C-diff 0 0 
*new tracking by facility during the project 
 
 One of the limitations of the project was that the history of antibiotic use and resistance 
was not always known for each of the residents. In addition, the accuracy of the monthly logs did 
not always match up 100% of the time with the lab reports requiring reverification. The time 
period since implementation of the ASP was less than 1 year, the months compared were not 
duplicative (i.e. January-December, one year) which made it more difficult to visually see the 
results comparatively. The sample size was small ranging between 37-39 residents and was 
limited to one facility. It was identified during the project that the Bestcare lab contract was not 
in effect until January 1, 2018, so data collection was done manually for September-December 




 Antibiotics are a limited resource and need to be used sparingly (U.S. Centers for Disease 
Control, 2013). The benefits of implementing an ASP at this LCTF showed a positive impact on 
the number of new antibiotics ordered, assisted in reducing the number of resistance cases, and 
ensured antibiotics were ordered as needed and verified by culture results. Not only do these 
outcomes positively impact this geriatric population but the community as well. Many of the 
nurses who work at this LTCF work part-time elsewhere, belong to local groups and 
associations, and have reported that they have shared their ASP program and what they have 
learned regarding becoming stewards of antibiotics with others outside of the facility. The 
findings from this project will be shared with the Houston Antibiotic Stewardship committee and 
will be presented in December 2018 in Las Vegas at the American Nursing Symposium 
conference in the hope of promoting positive social change on a state and national level.   
Recommendations 
 As the facility’s staff continues to be stewards of antibiotic use, there are several 
recommendations to implement so that the facility continues to improve and maintain its ASP 
program. The following are recommended solutions for not over ordering, overusing, or 
inappropriate use of antibiotics for the elderly population in this LTCF:  
• Conduct chart audits on those residents with infections and use the audit tool in 
the ASP program developed and provided in Appendix B. 
• Implement and use the monthly quality assurance summary form in Appendix C. 





• Conduct biannual education with the staff to maintain awareness and discuss 
statistics ongoing. 
• Continue to track number of new antibiotics ordered monthly and resistance cases 
monthly. 
• Implement the federally mandated Infection Preventionist job position, which is 
required this November 2018. 
• Customize the transfer form in Point Click Care to include antibiotic history of 
resident when transferring them out (when they were last on antibiotics or history 
of resistance) or use the form provided in Appendix C. 
• Consider extending the project to December 2018 to have comparative data. 
• Capture duration of antibiotic use as outlined in the QA policies. 
Contribution of the Doctoral Project Team 
 The doctoral project team included the preceptor, administrator, quality assurance nurse, 
DON, ADON, and the laboratory representative. Each person on the team provided guidance and 
assistance as outlined in Table 4. The team members who provided the most support were the 
ADON and administrator. The DON and QA nurse delegated their responsibilities to the ADON 
and the medical director relied on the facility staff to work with me. The ADON provided the 
unit monthly logs, answered questions, verified data, and worked with the unit manager to ensure 
the data captured was complete, accurate, and de-identified prior to giving it to me. The 
administrator assisted when the lab reports were needed and, when there were delays due to 
changes in the LTCF nursing management, in getting the lab reports to the facility and assigning 




findings, limitations, recommendations, and provided input on additional limitations to include in 
the report. The project team reviewed the final report and findings and are responsible for 
adoption of the final recommendations. It was mentioned by them director/preceptor that 
duration was not captured at this point and the project has the potential to be extended to include 
this data and to obtain a complete calendar year of data for comparison of July 2017 (pre-ASP) 
to July 2018 (post-ASP).  
Strength and Limitations of the Project  
 This project had many strengths and limitations. One strength was that the project team 
was committed to the project and worked with me to implement the ASP. Another strength was 
the outcome evaluation of the project demonstrated implementing an ASP does help to reduce 
over ordering and overuse of antibiotics in this LTCF. The project also provided support for the 
argument that many health care professionals are not aware how severe the overuse, misuse, and 
inappropriate use of antibiotics is at their facility. When conducting orientation and training with 
the staff many did not understand ASPs or the importance of their role in helping to reduce the 
problem of over ordering, inappropriate use, or ensuring culture results were back prior to 
antibiotic ordering. In a study conducted with a long-term acute care (LTAC) hospital where a 
survey was completed by the staff relating to antibiotic stewardship it was found that most were 
aware of the resistant bacteria but only 35% were confident in how to treat or reduce them 
(Mushtaq, et al., 2018). Finding online training modules that could be loaded into the facility 
Relias learning management system for ongoing training and orientation of new staff members 
was another strength of the project. These modules will provide sustainability of knowledge for 




newly hired nurses since inception of the ASP is another strength to increase knowledge and 
sustainability of this issue and project.  
 There were several limitations of the project as mentioned previously. These are 
summarized in Table 6.    
Table 6 
Limitations of the ASP Project  
Limitation        Possible Solution  
Antibiotic history not known for                                            Implement 
questionnaire on history 
the resident                                                                              for admission 
coordinator to collect  
 
Antibiotic resistance history not                                             Implement 
questionnaire on history 
known for the resident                                                            for admission 
coordinator to collect  
 
Small Sample Size -  1 facility                                               Increase sample size- 
include more     
n = 37.5                                                                                   facilities in the 
Houston area  
 
Duration of antibiotic use not measured                                 Collect duration data  
 
Manual logs maintained with no lab back up                          None available   
September 2016-December 2016  
 
 It is recommended as a future project that this project be replicated and send an invitation 
to all Houston LTCFs to participate in providing monthly data on new antibiotic starts, cases of 




that we can evaluate the effects of ASPs over the course of 1-year postimplementation in the 




Section 5: Dissemination Plan 
Introduction 
In this section, I describe the plans to disseminate ASP project work to the institution 
experiencing the problem in practice. The audiences and venues that would be appropriate for 
dissemination of the project to the broader nursing profession will be clarified and an analysis of 
self in my role as practitioner, scholar, and project manager drawing connections between this 
project experience, present state, and long-term professional goals will be presented. I also 
describe the completion of the project along with the challenges, solutions, and insights gained.  
Plans for Dissemination  
The results of the analyzed data were presented to the stakeholders and management team 
via a formal written report. The report summarized the number of new antibiotic starts, cases of 
C-diff, and resistance before versus after ASP implementation. In addition, findings regarding 
the monthly logs, quarterly QA reports, audits conducted, compliance with the ASP policies and 
procedures, and areas identified as needing improvement were incorporated into the report. Also 
included in the report were recommendations for the future and a request to allow me to return at 
the 24-month mark to evaluate the effectiveness over a 2-year period for publication. Audiences 
and venues that would be appropriate for dissemination of the project include the National 
Association of Directors of Nursing Association (NADONA), geriatric magazines, and Elsevier. 
In addition, I accepted an invitation to be a keynote speaker in Las Vegas at the annual American 
Nursing 2018 Symposium to sit on the scientific board and present this doctoral project. Another 
plan for dissemination includes working with the Houston Antibiotic Stewardship Committee to 




because, currently, the city of Houston focuses on the hospitals and LTCFs have no 
representation.  
Analysis of Self  
One thing that I have learned about myself that I did not know prior to this project is that 
I truly enjoy quality improvement and evidence-based practice. During this DNP project journey, 
I have assumed the role of scholar by researching current evidence and applying it to the systems 
and processes relative to antibiotic stewardship programming at this LTCF. I have assumed the 
role of project manager, leader, and practitioner. Through my work with the staff, many staff 
members have developed a better understanding of antibiotic stewardship and are practicing not 
overusing or misusing antibiotics. I feel I personally have made a huge impact on the facility 
staff, and their practices have improved based upon this doctoral project and focus on ASPs in 
this LTCF. participating in these types of activities in the future. This project has motivated me 
to want to become involved in our local ASP Houston Committee and team and has promoted 
my confidence to approach the Houston ASP Committee with my ideas of incorporating LTCFs 
into their programs and goals for our city.  
As a practitioner, I have grown tremendously during this project both professionally and 
personally. The specific areas I have grown in include integrating current science and evidence 
within an LTCF to benefit its residents, learning how to adapt to an ever-changing team of 
individuals throughout the length of the project, learning how to engage new and different team 
members throughout the project, gaining self-confidence as the leader of the project, overcoming 
my insecurities and working with a group that was initially strangers, researching and identifying 




prepare a formal presentation, and disseminating the information to the stakeholders. Another 
area that was a personal challenge for me was working in an area that was neither quiet nor 
private, and therefore not conducive to effective critical thinking. I initially worked in a private 
office with the first QA nurse, but when the staff changed, the new administrator moved my 
work area to the front desk of the facility. I did request initially another place to work and 
suggested an alternative solution that was not an office, but I was told that the front desk was 
where I was to work. This work space posed many obstacles for me, such as visitors immediately 
coming to me all day thinking I worked for the facility, staff members asking me questions that I 
could not answer as I do not work at the facility, and residents coming up to me at the desk all 
day wanting help or to visit. The environment was very loud and full of distractions, such as call 
lights going off for extended periods, door alarms sounding, wheel chair alarms going off, staff 
hustling about me, and meetings taking place near my work area, sometimes with the door open. 
I am a person who generally requires a quiet place to work, so this was a huge challenge for me. 
I overcame these obstacles and learned to block out the sounds and focus on the work for the 
project. Another challenge was protecting the privacy of the documents I was working with and 
my laptop which I brought with me. Also, I was not allowed to eat at the front desk, so I had to 
secure my work if I wanted to take a break or get a staff member to keep an eye on it for me. I 
learned to adjust to the work space provided and work with the team so that there was no 
negativity with the project. I laugh when I picture myself on my knees crawling under the desk to 
plug my laptop in, which was not an easy task to do! 
Another area of growth for me was balancing the relationship between the newly 




project but was limited in my authority to do so. The administrator who replaced the one who 
was terminated in December 2017 made it very clear that if I needed anything for the project I 
was to go through her, exclusively. This basically eliminated my ability to work with the team. 
She shared with me that “we don't like chatty people.” I recall one time I asked the physical 
therapy (P.T.) director if they had gotten a set of policies and procedures in their office yet for 
ASP and was informed later in the same day by the administrator that she “heard I had talked 
with the P.T. director” and that if I have any questions I must go through her. I learned that I 
needed to tap into all my practitioner team leading skills to work with the administrator and staff 
to make this project work. I discussed ideas and the project with the staff to gain insight, and 
then I went to the administrator with what was discussed. This way, I was still going through the 
administrator for decision making but through these interactions I was able to build a team with 
the staff whom I needed to support the project. Another strategy I used to overcome this 
restriction was, when I did informal education with the staff, I used it as a chance to build our 
relationship further, connect on a personal level, have side-bar discussions regarding the ASP 
goals, and gain their support. I brought the staff donuts and cookies, provided positive verbal 
reinforcement, and remained positive throughout the process. This worked well, and as I 
concluded the project, the staff were friendly and supportive, and even the administrator warmed 
up to me. In conclusion, I feel as a practitioner now, I am ready, able, and willing to conduct 
further projects/studies in the nursing profession and am motivated to continuing research and 




Completion of Project 
The completion of this doctoral project had its challenges. One challenge encountered 
was the lack of support by the nursing department in providing the collected data in a timely 
manner, and the administrator had to assist me in getting the data from the lab for the 20-month 
period enveloped within the project. In addition, the new DON had shown little to no interest in 
the project and was difficult to develop a working relationship with as she had just started in 
December and was overwhelmed with her new duties and in learning her new position within 
this LTCF. Her availability was limited, and her interest was waning. One way to overcome this 
challenge was to approach her when she acknowledged she had time to talk and to share what 
was needed for the project. Her response with this approach was positive and more welcoming. 
Another solution was to work with the ADON and try and get her to assist, which she did, 
providing the monthly de-identified unit logs even though she was not timely in getting these to 
me, and it took several requests over several weeks to get the information. The QA nurse did not 
conduct the chart audits as the policies and procedures required for January to May 2018; 
however, the monthly lab reports compared to the monthly unit logs and the documentation on 
the log did provide the required data regarding whether a culture was ordered, what the results 
were, and whether the antibiotic was ordered per policy and procedure. I was assigned to contact 
the lab directly to get the required monthly reports printed out; however, due to my relationship 
with the facility, the administrator had to establish the generation of the reports for this study and 
the reports needed to be de-identified for me. The administrator was frustrated that neither the 
DON or QA nurse had established online accounts with the lab and the administrator had to step 




patience, and using all the skills in one’s tool box to lead a project may not be enough and key 
management may need to get involved if the nursing leadership does not respond.   
Summary 
In summary, conducting this doctoral project has provided me the opportunity to evolve, 
learn, practice, and become competent in the essential competencies of the DNP program. This 
has been a roller coaster experience and has been challenging at times. It has provided me with 




















Ahern Gould, K. (2017). Johns Hopkins Nursing professional practice model: Strategies to 
advance nursing excellence. Dimensions of Critical Care Nursing, 36(6), 357. 
doi:10.1097/DCC.0000000000000273 
American Association for Colleges of Nursing. (2006). The essentials of doctoral education for 
advanced nursing practice. Retrieved from 
http://www.aacnnursing.org/Portals/42/Publications/DNPEssentials.pdf 
Barlem, T., Cosgrove, S., Abbo, L., MacDougall, C., Schuetz, A., Septimus, E., ... Dellit, T. 
(2016, April 13). Implementing an antibiotic stewardship program: Guidelines by the 
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of 
America. Clinical Infectious Disease, 62, e51-e77. 
http://dx.doi.org/doi:10.1093/cid/ciw118 
CDC Newsroom. (2013). Untreatable: Report by CDC details today’s drug-resistant health 
threats. Retrieved from https://www.cdc.gov/media/releases/2013/p0916-untreatable.html 
Dall, C. (2016). New rule mandates antibiotic stewardship in nursing homes. Retrieved from 
http://www.cidrap.umn.edu/news-perspective/2016/10/new-rule-mandates-antibiotic-
stewardship-nursing-homes 
Daneman, N., Bronskill, S., Grunier, A., Newman, A., Fisher, H., Rochon, P., (2015). Variability 
in antibiotic use across nursing homes and the risk of antibiotic-related adverse 
outcomes for individual residents. Retrieved from 
http://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2337257 




reduced antibiotic prescribing for self-limiting respiratory tract infections in primary care: 
Cohort study using electronic health records. Retrieved from 
http://www.bmj.com/content/354/bmj.i3410 
Hyuan, D. (2016). Why nursing homes and assisted-living facilities need to reduce antibiotic 
use—and how they can do it. Retrieved from http://www.pewtruss.org/en/research-and- 
 analysis/fact-sheets/2016/03/antibiotic-stewardship-in-long-term-care-facilities)  
Hopkins, John. (2017). Antimicrobial stewardship program. Retrieved from 
http://www.hopkinsmedicine.org/amp/ 
Ibrahim, O., Polk, R. (2014). Antimicrobial use metrics and benchmarking to improve 
stewardship outcomes. Retrieved from http://www.id.theclinics.com/article/S0891-
5520(14)00010-5/pdf 
Lee, C., Cho, I., B., Lee, S., (2013). Strategies to minimize antibiotic resistance. Retrieved from 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799537/ 













Michaelidis, C. I., Fine, M. J., Lin, C. J., Linder, J. A., Nowalk, M. P., Shields, R. K., … Smith, 
K. J. (2016). The hidden societal cost of antibiotic resistance per antibiotic prescribed in 
the United States: An exploratory analysis. BMC Infectious Diseases, 16, 655. 
http://doi.org/10.1186/s12879-016-1990-4  
Mongan, E. (2015). CMS proposal includes mandatory antibiotic stewardship programs. 
Retrieved from http://www.mcknights.com/news/cms-proposal-includes-mandatory-
antibiotic-stewardship-programs/article/427218/  
Mushtaq, A., Awali, R. A., Chandramohan, S., Krishna, A., Biedron, C., Jegede, O., & Chopra, 
T. (2017). Major article: Implementing an antibiotic stewardship program at a long-term 
acute care hospital in Detroit, Michigan. AJIC: American Journal of Infection Control, 
45e157-e160. doi:10.1016/j.ajic.2017.07.028 
Offiong, C. (2017). Antibiotics: Our first and last defense. Coordinating antibiotic stewardship 
activities in the Houston area. Retrieved from 
http://www.tmc.edu/news/2017/02/antibiotics-first-last-defense/ 
Nevada Public Health Organization. (2017). Nevada antimicrobial stewardship program. 
Retrieved from http://www.nevadapublichealthfoundation.org/wp-
content/uploads/2015/04/Norman-Wright-Abx-stewardship-barriers.pdf 
Newhouse, R. P., Johns Hopkins, U., Sigma Theta Tau, I., & Johns Hopkins, H. (2007). Johns 
Hopkins Nursing Evidence-based Practice Model and Guidelines. Indianapolis: Sigma 
Theta Tau International. 






Houston%20Antimicrobial%20Stewardship%20Symposium%20-%20E%20Rios.pdf   
Schaffer, M. A., Sandau, K., & Diedrrick, L. (2013). Evidence-based practice models for 
organizational change: Overview and practical applications. Journal of Advanced 
Nursing, 69(5), 1197–1209. doi: 10.1111/j.1365-2648.2012. 06122.x 
Smith, R., & Coast, J., (2013). The true cost of antimicrobial resistance. Retrieved from 
http://www.bmj.com/content/346/bmj.f1493.full 
Sprenger, M., (2015). How to stop antibiotic resistance? Here's a World Health Organisation 
prescription. Retrieved from https://www.theguardian.com/global-
development/2015/nov/20/antibiotic-awareness-week-resistance-world-health-
organisation-prescription 
Stone, N., (2013). Improving antibiotic use in nursing homes…why and how. Retrieved from 
https://www.ndhealth.gov/disease/hai/Docs/Stone_AntibioticUseinNH_NDWebinar_v1%
20LTC%20%5bCompatibility%20Mode%5d.pdf 
Tiberg, M., Torney, N., & Vander Horst, D., (2017). The long and the short of it: Development 
of antimicrobial stewardship programs in long-term care facilities. Retrieved from 
http://www.michiganpharmacists.org/Portals/0/104%20-      
%20VandeHorst,%20Tiberg,%20Torney.pdf?ver=2017-02-16-111802-297  
Triveldi, K., & Schooneveld, T. (2012). Antimicrobial stewardship in long-term care. Retrieved 
from https://www.medscape.com/viewarticle/762755 




States, 2013, http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf; Teena 
Chopra and Ellie J.C. Goldstein, “Clostridium difficile Infection in Long-Term Care 
Facilities: A Call to Action for Antimicrobial Stewardship,” Clinical Infectious Diseases 
60, no. S2 (2015): S72–S76, http://dx.doi.org/10.1093/cid/civ053.  
U.S. Department of Health and Human Services. Centers for Disease Control and Prevention, 
(2015). The core elements of antibiotic stewardship for nursing homes. Retrieved from 
https://www.cdc.gov/longermcare/pdfs/core-elements-antibiotic stewardship.pdf  
U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. 
(2017). Antibiotic resistance solutions initiative. Retrieved from 
https://www.cdc.gov/drugresistance/solutions-initiative/antibiotic-stewardship.html 
US Department of Health and Human Services. Centers for Disease Control and Prevention. 
(February 28, 2017). Core elements for of antibiotic stewardship for nursing homes. 
Retrieved from https://www.cdc.gov/longtermcare/prevention/antibiotic-
stewardship.html 
US Department of Health and Human Services. Centers for Disease Control and Prevention. 
(July 21, 2017). CDC/IHI antibiotic stewardship drivers and change package. Retrieved 
from https://www.cdc.gov/getsmart/healthcare/implementation.html  
U.S. Food and Drug Administration. (2017). Combating antibiotic resistance. Retrieved from 
https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm092810.htm 
White, K. M., Dudley-Brown, S., & Terharr, M. F. (2016). Translation of evidence into nursing 
and health care practice (2nd ed.). New York, NY: Springer. 





Young, D. (2012). Three steps to engaging stakeholders in your sustainability strategy. Retrieved 
from http://www.sustainablebrands.com/news_and_views/mar2012/three-steps-engaging-
stakeholders-your-sustainability-strategy 





Appendix A: Institutional Review Board Approval  




Appendix B: Chart Audit Tool 
New Antibiotic Starts- Phase One  
Effective July 10, 2017 
Instructions: Please complete this audit tool on the patient record to evaluate the antibiotic stewardship 
program. This tool is to be done weekly on all patients who received antibiotics by the Unit Manager. The 
completed tool is forwarded to the QA Nurse for incorporation into the quality assurance program.  
Week of: ______________________  (Week of: i.e. Monday- Sunday  6/26/17- 6/30/17)Jan  Feb 












(lab, x-ray, culture) 
on file showing what 
pathogen?  




07/10/17 UTI 14 days  U/A 7/10/17 Pending – atb started 
without result 
1      
2.      
3.      
4.      
5.      
6.      
7.      
8.      
9.      





Appendix C: New Antibiotic Starts- Phase One Monthly Results  
Data Collected by: ______________________________________________________ 
   First Name          Last Name           Title                  Date  
Monthly Totals: _______________  
Jan  Feb  March April  May  June  July    Aug  Sept  Oct  Nov  Dec 
Threshold for Compliance: 80%  
# New Antibiotic 
Orders  
#Residents who 
had Duration  
documented in 
the orders # days 
for antibiotic 





tests ordered to 
establish 
diagnosis for atb 
# results back 
prior to ordering 
atb  
i.e. 8 7/8  7/8 6/8 5/8 
Month Results: 
 
    
% compliance      
i.e.  87.5% 87.5% 75% 62.5% 
Month %: 
 
    
Calculation for % of compliance= 
# Residents with duration documented divided by total # new antibiotic starts x 100 = % 
# Residents with diagnosis to support atb order divided by total # new atb order starts x 100 = % 
# Residents with tests ordered to establish dx divided by total # new atb order starts x 100 = % 




Appendix D: Inter-facility Infection Control Transfer Form 
 
